CytomX Therapeutics (CTMX) Intangibles (2014 - 2026)
CytomX Therapeutics (CTMX) reported Intangibles of $401000.0 for Q1 2026, down 26.69% on a YoY basis from $547000.0 in Q1 2025, and down 8.45% quarter-over-quarter from $438000.0 in Q4 2025.
CytomX Therapeutics (CTMX) Intangibles (2014 - 2026) Analysis & Trends
CytomX Therapeutics has reported Intangibles for 13 years, with the latest figure at $401000.0 in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 26.69% year-over-year to $401000.0; the trailing twelve-month figure through Mar 2026 stood at $401000.0 (down 26.69% YoY), and the FY2025 full-year result was $438000.0, down 24.87% from the prior year.
- Intangibles for Q1 2026 stood at $401000.0, down from $438000.0 in the prior quarter.
- The five-year high for Intangibles was $984000.0 in Q1 2022, with the low at $401000.0 in Q1 2026.
- Historically, Intangibles has averaged $692705.9 across 5 years, with a median of $693000.0 in 2024.
- Annual changes were most pronounced in 2022 — Intangibles declined 12.92% — and 2026, when it decreased 26.69%.
- CytomX Therapeutics' Intangibles stood at $875000.0 in 2022, then dropped by 16.69% to $729000.0 in 2023, then fell by 20.03% to $583000.0 in 2024, then retreated by 24.87% to $438000.0 in 2025, then slipped by 8.45% to $401000.0 in 2026.
- The last three Intangibles figures came in at $401000.0 (Q1 2026), $438000.0 (Q4 2025), and $474000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | 401,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 401,000.00 |
| Dec 31, 2025 | 438,000.00 |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Mar 31, 2024 | 693,000.00 |
| Dec 31, 2023 | 729,000.00 |
| Sep 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 802,000.00 |
| Mar 31, 2023 | 839,000.00 |
| Dec 31, 2022 | 875,000.00 |
| Sep 30, 2022 | 911,000.00 |
| Jun 30, 2022 | 948,000.00 |
| Mar 31, 2022 | 984,000.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 1.06 Mn |
| Jun 30, 2021 | 1.09 Mn |